Outcomes with durvalumab by tumour PD-L1 expression in unresectable, stage III non-small-cell lung cancer in the PACIFIC trial

2020219 citationsJournal Articlegreen Open Access

Authors

Good health and well-being

Published in: Annals of Oncology

Volume 31, Issue 6, pp. 798-806

Field-Weighted Citation Impact: 11.72